WooGene B&G Co., Ltd (KOSDAQ: 018620)

South Korea flag South Korea · Delayed Price · Currency is KRW
896.00
-16.00 (-1.75%)
Dec 20, 2024, 9:00 AM KST
-27.04%
Market Cap 25.88B
Revenue (ttm) 58.64B
Net Income (ttm) 1.24B
Shares Out 28.89M
EPS (ttm) 42.95
PE Ratio 20.86
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,767
Open 919.00
Previous Close 912.00
Day's Range 895.00 - 919.00
52-Week Range 830.00 - 1,259.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 21, 2025

About WooGene B&G

WooGene B&G Co., Ltd. engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally. It offers antibiotic, vaccine, nutrient, anti-inflammation, metabolic stimulant, and iron supplement products for swine, poultry, cattle, aquatic animals, companion animals, and raw materials, as well as operates vaccine research center. The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001. WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Hw... [Read more]

Industry Pharmaceutical Preparations
Founded 1977
Employees 84
Stock Exchange KOSDAQ
Ticker Symbol 018620
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.